InsidersTradesSigma
Browse the full directors' dealings record of BriaCell Therapeutics Corp., a publicly traded company based in United States. Shares trade on US US, under the oversight of SEC (Form 4). Market capitalisation: €28.6m. The latest transaction was reported on 20 May 2024 (Acquisition). Among the most active insiders: Bondarenko Jamieson. Every trade is openly available.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
3 of 3 declarations